Search
Search Results
-
Dosimetric comparison of proton therapy and CyberKnife in stereotactic body radiation therapy for liver cancers
Stereotactic body radiation therapy (SBRT) has been increasingly used for the ablation of liver tumours. CyberKnife and proton beam therapy (PBT) are...
-
The current landscape of stereotactic body radiation therapy for metastatic castration-resistant prostate cancer
BackgroundThe onset of castration-resistance is associated with dismal outcomes in patients with prostate cancer (PCa). Metastasis directed therapy...
-
Treatment outcomes of stereotactic body radiation therapy for primary and metastatic sarcoma of the spine
PurposeThis study evaluated the treatment outcomes of spine stereotactic body radiation therapy (SBRT) in sarcoma patients.
Materials and methods ...
-
Treatment outcomes of stereotactic body radiation therapy for pulmonary metastasis from sarcoma: a multicenter, retrospective study
PurposeThe aim of this study was to evaluate the treatment outcomes and potential dose-response relationship of stereotactic body radiation therapy...
-
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer
BackgroundImmunotherapy targeting the PD-1/PD-L1 pathway is a standard of care in a number of metastatic malignancies, but less than a fifth of...
-
Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience
BackgroundStandard treatment options for patients with metastatic urothelial cancer (mUC) include systemic platinum-based chemotherapy,...
-
A safety study of intraoperative radiation therapy following stereotactic body radiation therapy and multi-agent chemotherapy in the treatment of localized pancreatic adenocarcinoma: study protocol of a phase I trial
BackgroundLocalized pancreatic adenocarcinoma carries a poor prognosis even after aggressive therapy. Up to 40% of patients may develop locoregional...
-
Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer
ObjectiveStereotactic Body Radiation Therapy (SBRT) has been found beneficial for adrenal gland metastases (AGMs) with a high local control rate and...
-
Current and Future Perspectives of Combining Chemotherapy and Stereotactic Body Radiation Therapy with Immunotherapy in the Treatment of Lung Cancer
Lung cancer is a huge public health concern all over the world, including India, and for many years, the gold standard treatment has been the...
-
Radiation pneumonitis prediction after stereotactic body radiation therapy based on 3D dose distribution: dosiomics and/or deep learning-based radiomics features
BackgroundThis study was designed to establish radiation pneumonitis (RP) prediction models using dosiomics and/or deep learning-based radiomics...
-
Stereotactic Radiotherapy in the Treatment of Prostate Cancer
Stereotactic body radiotherapy (SBRT) is a technologically sophisticated form of radiotherapy and well-established treatment option for patients with...
-
Stereotactic body radiation therapy for prostate cancer: a study comparing 3-year genitourinary toxicity between CyberKnife and volumetric-modulated arc therapy by propensity score analysis
BackgroundTo investigate whether the rate of stereotactic body radiation therapy-related (SBRT-related) genitourinary (GU) toxicity is lower in...
-
Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: a prospective, randomized, open-label, single center trial
BackgroundThe role of adjuvant radiation in pancreatic adenocarcinoma (PDAC) remains unclear. We aimed to investigate the efficacy of gemcitabine...
-
The Effect of Video-Based Education on Anxiety of Patients Receiving Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Patients receiving stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) may have an anxiety due to unknown aspects of the...
-
A phase 2 study of stereotactic body radiation therapy for squamous cell carcinoma of the head and neck (SHINE): a single arm clinical trial protocol
BackgroundCancers of the head and neck region are often characterized by locally advanced, non-metastatic disease. Standard treatments for advanced...
-
Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost
BackgroundTo evaluate acute and late genitourinary and gastrointestinal toxicities and patient reported urinary and sexual function following...
-
Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy
ObjectivesThe purpose of this study was to determine if vertebral body and splenic dosimetry was associated with the development of lymphopenia in...
-
Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy
IntroductionConventional treatment of pulmonary metastatic sarcoma primarily involves surgery, with systemic therapy added in select patients....
-
Comparison of stereotactic body radiation therapy versus fractionated radiation therapy for primary liver cancer with portal vein tumor thrombus
BackgroundTo compare the clinical outcomes of stereotactic body radiation therapy (SBRT) and fractionated radiation therapy (FRT) for primary liver...
-
Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI
BackgroundThe use of treatment planning prostate MRI for Stereotactic Body Radiation Therapy (SBRT) is largely a standard, yet not all patients can...
